The US Food and Drug Administration (FDA) and CDC (Centers for Disease Control and Prevention) are looking into 4 complaints about illness linked to Abbott Nutrition formula produced in a Michigan factory.
The US Food and Drug Administration has started an inspection of the Sturgis, Michigan Abbott Nutrition plant that manufactured powedered infant formula that has been linked to 3 reports of Cronobacter sakazakii infections and 1 report of Salmonella Newport infection in infants.1 All of the infants required hospitalization and 1 died.
The findings found so far include multiple positive C sakazakii results from samples. A review of records showed potential environmental contamination from C sakazakii as well as product that had been destroyed because of the presence of the bacteria.
Abbott Nutrition started a voluntary recall of the formula yesterday, February 17, 2022. The affected products are Similac, Alimentum, or EleCare with the following information that can be found on the bottom:
Reference
1. US Food and Drug Administration. FDA investigation of Cronobacter and Salmonella complaints: powdered infant formula. Published February 18, 2022. Accessed February 18, 2022. https://www.fda.gov/food/outbreaks-foodborne-illness/fda-investigation-cronobacter-and-salmonella-complaints-powdered-infant-formula-february-2022
Major congenital malformations not linked to first trimester tetracycline use
November 22nd 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Higher pregnancy risks associated with maternal hidradenitis suppurativa
November 8th 2024A study of over 1 million births in Quebec reveals that pregnant women with hidradenitis suppurativa face increased risks of pregnancy complications and long-term health issues for both themselves and their offspring.